首页> 外国专利> DETECTION OF CANCER AND ABNORMAL PREGNANCY USING MONOCLONAL ANTIBODIES SPECIFIC FOR HCG ISOFORMS

DETECTION OF CANCER AND ABNORMAL PREGNANCY USING MONOCLONAL ANTIBODIES SPECIFIC FOR HCG ISOFORMS

机译:使用HCG同种型特异的单克隆抗体检测癌症和异常妊娠

摘要

Human chorionic gonadotropin (hCG) exists in blood and urine as a variety of isoforms, one of which contains peptide bond cleavages within its beta subunit and is referred to as nicked hCG (hCGn). This hCGn isoform appears more prevalent in the urine of patients with certain malignancies and possibly in other diseases of pregnancy. The present invention is directed to two monoclonal antibodies to an isoform of hCGn isolated from a choriocarcinoma patient. Two-site immunometric assays have been developed using these antibodies, designated B151 and B152. The former exhibits good specificity for hCGn independent of the source of the hCGn, that form excreted by choriocarcinoma patients, or the form of hCGn from normal pregnancies. The latter antibody, B152, is uniquely sensitive to the carbohydrate moieties of choriocarcinoma hCG, nicked or non-nicked, since its recognition of ligand is dependent upon carbohydrate differences rather than differences in peptide bond. These two immunometric assays provide novel diagnostic tools based on direct measurement of these hCG isoforms.
机译:人绒毛膜促性腺激素(hCG)以多种同种型形式存在于血液和尿液中,其中一种在其β亚基内包含肽键裂解,被称为切口型hCG(hCGn)。这种hCGn亚型在某些恶性肿瘤患者的尿液中似乎更普遍,并且在其他妊娠疾病中也可能更为普遍。本发明涉及从绒毛膜癌患者分离的针对hCGn同种型的两种单克隆抗体。已经使用这些抗体开发了两点免疫测定,命名为B151和B152。前者对人绒毛膜促性腺激素表现出良好的特异性,而与绒毛膜癌患者排泄的人绒毛膜促性腺激素的来源或正常妊娠的人绒毛膜促性腺激素的形式无关。后一种抗体B152对绒毛膜绒毛膜癌hCG的有缺口或无缺口的碳水化合物部分具有独特的敏感性,因为其对配体的识别取决于碳水化合物的差异而不是肽键的差异。这两种免疫测定法基于这些hCG亚型的直接测量提供了新颖的诊断工具。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号